HEADER PROTEIN BINDING 02-NOV-17 6EVQ TITLE SOLUTION NMR STRUCTURE OF EB1 C TERMINUS (191-260) WITH A SMALL TITLE 2 MOLECULE BOUND INTO THE SXIP BINDING SITE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MICROTUBULE-ASSOCIATED PROTEIN RP/EB FAMILY MEMBER 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: APC-BINDING PROTEIN EB1,END-BINDING PROTEIN 1,EB1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: MAPRE1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS END-BINDING PROTEIN, EB1, MICROTUBULES, SXIP, MICROTUBULE-ASSOCIATED KEYWDS 2 PROTEIN RP/EB FAMILY MEMBER 1, MAPRE1, APC-BINDING PROTEIN EB1, KEYWDS 3 PROTEIN BINDING EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR I.L.BARSUKOV,T.B.ALMEIDA REVDAT 2 08-MAY-19 6EVQ 1 REMARK REVDAT 1 07-FEB-18 6EVQ 0 JRNL AUTH T.B.ALMEIDA,A.J.CARNELL,I.L.BARSUKOV,N.G.BERRY JRNL TITL TARGETING SXIP-EB1 INTERACTION: AN INTEGRATED APPROACH TO JRNL TITL 2 THE DISCOVERY OF SMALL MOLECULE MODULATORS OF DYNAMIC JRNL TITL 3 BINDING SITES. JRNL REF SCI REP V. 7 15533 2017 JRNL REFN ESSN 2045-2322 JRNL PMID 29138501 JRNL DOI 10.1038/S41598-017-15502-6 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER A. T. ET.AL. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6EVQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1200007326. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1 MM [U-13C; U-15N] EB1, 5 MM 2 REMARK 210 -(1-CYCLOPENTYLTETRAZOL-5-YL)SULFANYL-N-(2-FURYLMETHYL) REMARK 210 PROPANAMIDE, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC REMARK 210 ALIPHATIC; 2D 1H-13C HSQC REMARK 210 AROMATIC; 3D CBCA(CO)NH; 3D REMARK 210 HBHA(CO)NH; 3D 1H-13C NOESY REMARK 210 ALIPHATIC; 3D 1H-13C NOESY REMARK 210 AROMATIC; 2D 1H-1H NOESY; 2D 1H- REMARK 210 1H TOCSY; 3D HCCH-TOCSY; 3D 1H- REMARK 210 15N NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCEIII REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ARIA, CCPNMR ANALYSIS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : ALL CALCULATED STRUCTURES REMARK 210 SUBMITTED REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9540 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 235 -62.08 -134.41 REMARK 500 1 ASN B 235 -62.27 -135.13 REMARK 500 2 ASN A 235 -61.20 -133.77 REMARK 500 2 GLU A 251 -67.73 -126.63 REMARK 500 2 ASN B 235 -61.53 -134.64 REMARK 500 2 GLU B 251 -67.29 -127.14 REMARK 500 3 ASN A 235 -63.65 -136.19 REMARK 500 3 ASN B 235 -64.50 -136.43 REMARK 500 4 GLU A 234 -53.06 -121.87 REMARK 500 4 ASN A 235 -66.39 -126.54 REMARK 500 4 GLU A 251 -44.97 -147.06 REMARK 500 4 GLU A 258 99.81 -69.91 REMARK 500 4 GLU B 234 -53.99 -122.22 REMARK 500 4 ASN B 235 -67.58 -125.49 REMARK 500 4 GLU B 251 -44.75 -146.48 REMARK 500 4 GLU B 258 99.57 -69.78 REMARK 500 5 GLU A 234 -54.98 -121.18 REMARK 500 5 ASN A 235 -54.07 -135.98 REMARK 500 5 GLU B 234 -55.26 -121.32 REMARK 500 5 ASN B 235 -53.28 -137.10 REMARK 500 6 ASN A 235 -61.28 -132.74 REMARK 500 6 ASN B 235 -61.45 -132.92 REMARK 500 7 GLU A 234 -51.69 -120.31 REMARK 500 7 ASN A 235 -61.50 -132.66 REMARK 500 7 GLU B 234 -51.65 -120.49 REMARK 500 7 ASN B 235 -61.81 -133.15 REMARK 500 8 ASN A 235 -60.98 -133.97 REMARK 500 8 ASP A 257 46.24 -109.50 REMARK 500 8 ASN B 235 -61.19 -134.31 REMARK 500 8 ASP B 257 46.39 -109.65 REMARK 500 9 ASN A 235 -62.95 -133.83 REMARK 500 9 GLU A 251 -173.10 57.36 REMARK 500 9 ASN B 235 -62.77 -134.66 REMARK 500 9 GLU B 251 -173.10 58.59 REMARK 500 10 ASN A 235 -62.63 -141.25 REMARK 500 10 ASP A 250 96.47 -66.54 REMARK 500 10 GLU A 251 -52.60 -159.23 REMARK 500 10 GLU B 234 -60.53 -93.07 REMARK 500 10 ASN B 235 -62.69 -142.75 REMARK 500 10 ASP B 250 96.60 -66.25 REMARK 500 10 GLU B 251 -52.49 -159.60 REMARK 500 11 GLU A 234 -52.08 -120.56 REMARK 500 11 ASN A 235 -60.46 -133.32 REMARK 500 11 GLU B 234 -51.92 -120.71 REMARK 500 11 ASN B 235 -60.41 -134.04 REMARK 500 12 ASN A 235 -62.57 -131.60 REMARK 500 12 ASN B 235 -63.40 -131.83 REMARK 500 13 ASN A 235 -62.83 -134.90 REMARK 500 13 ASN B 235 -63.35 -135.15 REMARK 500 14 GLU A 234 -50.62 -121.18 REMARK 500 REMARK 500 THIS ENTRY HAS 71 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue C05 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue C05 B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34192 RELATED DB: BMRB REMARK 900 SOLUTION NMR STRUCTURE OF EB1 C TERMINUS (191-260) WITH A SMALL REMARK 900 MOLECULE BOUND INTO THE SXIP BINDING SITE DBREF 6EVQ A 191 260 UNP Q61166 MARE1_MOUSE 191 260 DBREF 6EVQ B 191 260 UNP Q61166 MARE1_MOUSE 191 260 SEQRES 1 A 70 ASP GLU ALA ALA GLU LEU MET GLN GLN VAL LYS VAL LEU SEQRES 2 A 70 LYS LEU THR VAL GLU ASP LEU GLU LYS GLU ARG ASP PHE SEQRES 3 A 70 TYR PHE GLY LYS LEU ARG ASN ILE GLU LEU ILE CYS GLN SEQRES 4 A 70 GLU ASN GLU GLY GLU ASN ASP PRO VAL LEU GLN ARG ILE SEQRES 5 A 70 VAL ASP ILE LEU TYR ALA THR ASP GLU GLY PHE VAL ILE SEQRES 6 A 70 PRO ASP GLU GLY GLY SEQRES 1 B 70 ASP GLU ALA ALA GLU LEU MET GLN GLN VAL LYS VAL LEU SEQRES 2 B 70 LYS LEU THR VAL GLU ASP LEU GLU LYS GLU ARG ASP PHE SEQRES 3 B 70 TYR PHE GLY LYS LEU ARG ASN ILE GLU LEU ILE CYS GLN SEQRES 4 B 70 GLU ASN GLU GLY GLU ASN ASP PRO VAL LEU GLN ARG ILE SEQRES 5 B 70 VAL ASP ILE LEU TYR ALA THR ASP GLU GLY PHE VAL ILE SEQRES 6 B 70 PRO ASP GLU GLY GLY HET C05 A 301 41 HET C05 B 301 41 HETNAM C05 (2~{R})-2-[(1-CYCLOPENTYL-1,2,3,4-TETRAZOL-5-YL) HETNAM 2 C05 SULFANYL]-~{N}-(FURAN-2-YLMETHYL)PROPANAMIDE FORMUL 3 C05 2(C14 H19 N5 O2 S) HELIX 1 AA1 ASP A 191 GLU A 232 1 42 HELIX 2 AA2 PRO A 237 TYR A 247 1 11 HELIX 3 AA3 GLU B 192 GLU B 232 1 41 HELIX 4 AA4 PRO B 237 TYR B 247 1 11 SITE 1 AC1 5 GLU A 225 LEU A 246 TYR A 247 THR A 249 SITE 2 AC1 5 TYR B 217 SITE 1 AC2 5 TYR A 217 GLU B 225 LEU B 246 TYR B 247 SITE 2 AC2 5 THR B 249 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1